Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial Hypertension
NCT07177703
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Pulmonary Arterial Hypertension (PAH)
Interventions
DRUG:
Treprostinil
Sponsor
Shanghai Zhongshan Hospital